FMOD and bladder transitional cell carcinoma: Finally, we assessed the impact of HS3ST3B1, FMOD, CSPG4, ALDH1A1, CYP1B1, and ENO1 expression on the OS of patients with BLCA via univariate and multifactorial Cox regression analyses.